Depression is a major health problem with a high prevalence and a heavy socioeconomic
burden in western societies. It is associated with atrophy and impaired functioning of cortico …

Background Current practice for selecting pharmacological and non-pharmacological
antidepressant treatments has yielded low response and remission rates in Major …

Episodic memory deficits have increasingly been recognized as a cognitive feature of
depression. To quantify these deficits and determine how they are moderated by various …

Major depressive disorder is among the most prevalent psychiatric disorders, exacting a
substantial personal, social, and economic toll. Antidepressant treatment typically involves …

A growing number of studies have used neuroimaging to further our understanding of how
brain structure and function are altered in major depression. More recently, these techniques …

Objective The aim of this study is to investigate the effects of exercise as an add-on therapy
with antidepressant medication and cognitive behavioral group therapy (CBGT) on treatment …

Several previous functional magnetic resonance imaging (fMRI) studies have demonstrated
the predictive value of brain activity during emotion processing for antidepressant response …

Studies of clinical populations that combine MRI data generated at multiple sites are
increasingly common. The Canadian Biomarker Integration Network in Depression (CAN …

Background: Abnormal regional cerebral blood flow (rCBF) and grey matter volume have
been frequently reported in patients with major depressive disorder (MDD). However, it is …

Background In order to reduce unsuccessful treatment trials for depression, neuroimaging
and genetic information can be considered as biomarkers. Together with machine‐learning …